AI Verdict
ZTS has stronger fundamentals based on our AI analysis.
CI vs ZTS Fundamental Comparison
| Metric | CI | ZTS |
|---|---|---|
| Revenue | $274.9B | $9.5B |
| Net Income | $6.0B | $2.7B |
| Net Margin | 2.2% | 28.2% |
| ROE | 14.3% | 80.2% |
| ROA | 3.8% | 17.3% |
| Current Ratio | 0.85x | 3.03x |
| Debt/Equity | 0.74x | 2.71x |
| EPS | $22.18 | $6.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CI vs ZTS: Frequently Asked Questions
Is CI or ZTS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ZTS has stronger fundamentals. CI is rated BUY (76% confidence) while ZTS is rated BUY (78% confidence). This is not investment advice.
How does CI compare to ZTS fundamentally?
Cigna Group has ROE of 14.3% vs Zoetis Inc.'s 80.2%. Net margins are 2.2% vs 28.2% respectively.
Which stock pays higher dividends, CI or ZTS?
CI has a dividend yield of N/A or no dividend while ZTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CI or ZTS for long term?
For long-term investing, consider that CI has BUY rating with 76% confidence, while ZTS has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CI vs ZTS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CI vs ZTS, the AI consensus favors ZTS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.